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Review
Nicholas J. Bradshaw*, William Hennah and Dinesh C. Soares*
NDE1 and NDEL1: twin neurodevelopmental 
proteins with similar ‘nature’ but different 
‘nurture’
Abstract: Nuclear distribution element 1 (NDE1, also 
known as NudE) and NDE-like 1 (NDEL1, also known as 
Nudel) are paralogous proteins essential for mitosis and 
neurodevelopment that have been implicated in psychiat-
ric and neurodevelopmental disorders. The two proteins 
possess high sequence similarity and have been shown 
to physically interact with one another. Numerous lines 
of experimental evidence in vivo and in cell culture have 
demonstrated that these proteins share common func-
tions, although instances of differing functions between 
the two have recently emerged. We review the key aspects 
of NDE1 and NDEL1 in terms of recent advances in struc-
ture elucidation and cellular function, with an emphasis 
on their differing mechanisms of post-translational modi-
fication. Based on a review of the literature and bioin-
formatics assessment, we advance the concept that the 
twin proteins NDE1 and NDEL1, while sharing a similar 
‘nature’ in terms of their structure and basic functions, 
appear to be different in their ‘nurture’, the manner in 
which they are regulated both in terms of expression and 
of post-translational modification within the cell. These 
differences are likely to be of significant importance in 
understanding the specific roles of NDE1 and NDEL1 in 
neurodevelopment and disease.
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Introduction
Nuclear distribution element 1 (NDE1, also known as NudE) 
and NDE-like 1 (NDEL1, also known as Nudel) are a pair of 
highly similar coiled-coil-containing proteins (Figure 1), 
believed to have evolved from a common ancestral gene, 
such as the NudE gene of Aspergillus nidulans, after which 
they were named (1–5). Both of these proteins are known 
to be critical for neurodevelopment and have been impli-
cated in a range of mental health measures and neurode-
velopmental conditions. Copy number variations (CNVs) 
at the 16p13.11 chromosomal locus, that contains the NDE1 
gene among others, have been associated with intellec-
tual disability, autism, attention deficit hyperactivity dis-
order, schizophrenia and epilepsy (6–18). In contrast, the 
region of the 17p13.1 locus where NDEL1 resides has not 
been directly implicated in brain disorders through CNV 
analysis. However, it should be noted that genomic struc-
tural variation at the 16p13.11 locus is more common than 
at 17p13.1, even among healthy individuals [database of 
genomic variants; ref. (19)]. Of the genes disrupted by CNVs 
at 16p13.11, disruption of normal NDE1 function stands out 
as the most likely cause of the associated mental health 
problems due to the known functional roles of the NDE1 
and NDEL1 proteins through interaction with Disrupted In 
Schizophrenia 1 (DISC1), a molecule strongly implicated in 
risk of mental illness (reviewed in refs. 20–23).
The DISC1 gene was discovered because it is directly 
disrupted by a balanced translocation that segregates 
with major mental illness in a single large Scottish pedi-
gree (24, 25). Initial efforts to characterize DISC1 function 
revolved around attempts to discover its protein interac-
tion partners, on the assumption that such knowledge 
would suggest biological functions in which the novel 
and unique DISC1 protein might partake. This led to 
the formation of the DISC1 pathway hypothesis, which 
hypothesized that disruption of components of the DISC1 
pathway could influence susceptibility to schizophrenia 
and related disorders (26, 27). NDE1 and NDEL1 were both 
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Figure 1 Multiple sequence alignment of NDE1 and NDEL1 orthologs. 
Orthologs of NDE1 and NDEL1 across vertebrate species were identified using the UCSC Genome Browser (http://genome-euro.ucsc.edu). 
These were aligned initially using Clustal Omega (108, 109) with further manual editing for optimum alignment. The sequence numbering at the 
top of each alignment block corresponds to the sequence of human NDE1. Conserved residues are colored with a red background; conserva-
tively substituted residues are shown with a yellow background. The location of the N-terminal coiled-coil α-helical domain (residues ∼10–185) 
and the predicted C-terminal α-helix (residues ∼247–278) are shown above the alignment. Consensus amino acids are shown at the bottom of 
the each alignment block (uppercase is strictly conserved; lowercase is consensus level  > 0.5; ! is I or V; $ is L or M; % is F or Y;  =  is N, D, Q or 
E). Despite 60% sequence identity there are at least 18 specific phosphorylation sites for each human protein – i.e., phosphorylation possible 
only in one protein. Some of these phosphorylation sites have been derived from high-throughput proteomic screening using mass spectrom-
etry (90), while others have been experimentally verified in the cell. See the main text and Table 2 for more information. Those sites known to 
be specific to either NDE1 or NDEL1 are highlighted with a green filled oval under the corresponding star; black star = phosphorylation site in 
NDE1; orange star = phosphorylation site in NDEL1; pink star = phosphorylation site in both NDE1 and NDEL1; cyan block = palmitoylation site in 
both proteins. The figure was generated with ESPript v2.2 (111).
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found to directly interact with DISC1 (28–33) and have 
since become central to this hypothesis (20–23).
In genetic association studies of NDE1 and NDEL1 
using single-nucleotide polymorphisms and haplotypes, 
both genes have provided evidence for involvement in 
mental illness phenotypes, with significant association 
ascertained independently in a Finnish family cohort 
for schizophrenia (26, 34), and in a Caucasian-American 
schizophrenia cohort where the association depended 
on the status of a common variant in DISC1 (C704) (29). A 
variant at the NDEL1 locus has also been demonstrated to 
associate with schizophrenia in interaction with an inde-
pendently significant variant from the CIT gene, encoding 
another DISC1 interacting protein (35). However, such sig-
nificant associations have not been uniformly observed 
(35–39), nor have they yet been found to be significant in 
genome-wide association studies (40).
Deletions of the 16p13.11 locus are also associated 
with mild microcephaly (7). Again, NDE1 stands out as the 
most likely gene to be responsible for the greater part of 
the effect, as extreme microcephaly with lissencephaly 
was reported in multiple patients with biallelic frameshift 
mutations leading to truncation of the NDE1 protein 
(41, 42). Additionally, a biallelic mutant predicted to 
abolish NDE1 expression has been reported in patients 
with microhydranencephaly (43). A recent study investi-
gating association of the 16p13.11 region with microceph-
aly and a fetal brain disruption-like phenotype also found 
a similar phenotype to occur in two patients with deletion 
of one copy of 16p13.11, combined with a frameshift muta-
tion in the remaining NDE1 gene (44).
Therefore, genetic association evidence exists impli-
cating both NDE1 and NDEL1 in psychiatric illness, with 
additional evidence from CNV and gene-disrupting muta-
tions implicating NDE1 specifically in a wider array of 
neurodevelopmental conditions. In this review, we assess 
both proteins, with a focus on what properties they share 
in common, but also the manner in which their regulation 
and functions differ – differences that may help explain 
their specific roles in neurodevelopment and disease and 
why two highly similar proteins have been retained in ver-
tebrate evolution.
NDE1 and NDEL1 play overlapping 
roles in the cell and developing 
brain
NDE1 and NDEL1 were initially identified as part of a 
highly evolutionarily conserved pathway consisting of 
the motor protein dynein and its various ancillary and 
regulatory proteins (1–5). These included the developmen-
tally critical Lissencephaly 1 protein [LIS1, encoded by the 
PAFAH1B1 gene; ref. (45)]. NDE1 is known to recruit LIS1 to 
dynein, where they together induce a force-state, facilitat-
ing the movement of dynein along microtubules. In con-
trast, on its own NDE1 inhibits dynein motility by causing 
it to dissociate from the microtubules (46). NDEL1 appears 
to act in the same way, with its LIS1-binding N-terminus 
stimulating the movement of dynein, while its C-terminus, 
expressed alone, causes dynein-microtubule dissociation 
(47). Interestingly, while both proteins can interact with 
the intermediate chain of the dynein complex (2, 48), 
NDEL1, but not NDE1, can also bind the motor domain of 
dynein, in its heavy-chain (1, 2, 46). Additionally, NDE1 
is known to compete with dynactin (dynein-activator) for 
binding to the dynein intermediate chain, and possesses a 
distinct site for interaction with dynein light chain 8 (LC8) 
(49). NDEL1 is not known to share this latter feature, and 
the LC8 binding region of NDE1 (residues 200–203) is only 
partially conserved in NDEL1 (Figure 1).
NDEL1 is known to affect many aspects of dynein func-
tion, including transport along the microtubule network 
of vesicles (50, 51) and lysosomes (52), with effects on the 
correct structure of the Golgi apparatus, as well as on the 
transport of intermediate filament proteins (53), short 
microtubules and viral glycoproteins (54). Of these known 
roles of NDEL1, NDE1 has also been shown to affect the 
size of the Golgi apparatus, with knockdown of NDE1 in 
HeLaM cells having a smaller effect than NDEL1, but with 
the double-knockdown having a greater effect still, imply-
ing that they can partially compensate for each other’s 
loss (55). Peptides derived from each of NDE1 and NDEL1 
also affect actin transport in a squid axonal model (56).
NDE1 and NDEL1 have also been demonstrated to be 
of significant importance in mitosis, with Nde1 knockout 
mice displaying frequent instances of misaligned spindles 
in their cortical progenitor cells (57). Use of an antibody 
against both NDE1 and NDEL1 to disrupt their function 
induces similar defects, and disrupts the dynein-related 
removal of proteins from the kinetochore essential for 
mitotic progression at metaphase (48). Interestingly, this 
effect may be mediated by NDE1 alone, as suppression 
of NDE1, but not NDEL1, stopped dynein from localizing 
to the kinetochore and the cells from passing this mitotic 
checkpoint (58). This NDE1-specific role has, however, 
been contradicted by another study (59), while expression 
of Xenopus Ndel1 alone was sufficient to rescue spindle 
alignment defects caused by depletion of endogenous 
Nde1 and Ndel1 from egg extracts (60). NDEL1 has also 
been shown to stabilize dynein at the kinetochore (61) as 
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well as having additional mitotic roles in the breakdown 
of the nuclear envelope (62) and the assembly of the lamin 
B spindle matrix (63). NDE1 also has a dynein LC8-related 
effect on ciliogenesis during mitosis (64).
Nde1 knockout mice display thinning of the superfi-
cial layers of the cerebral cortex leading to a reduction in 
brain volume (57) reminiscent, but not as severe as, the 
microcephaly displayed in human patients with non-func-
tional NDE1 genes (41, 42). This appears to occur due to 
defects in neuronal migration and neurogenesis amongst 
neuronal progenitors, potentially as a result of incorrect 
orientation of the spindle during cell division (57). Addi-
tional effects of mouse Nde1 on cortical neurodevelop-
ment in conjunction with Lis1 via radial glial cell function 
and spatial co-ordination of MAPK signaling pathways 
have also been described (65, 66).
In contrast Ndel1 knockout mice are not viable, with 
blastocysts perishing within days of fertilization (51). 
Studies depleting the level of Ndel1 in the developing 
mouse by various means, have also demonstrated defects 
in cortical neuronal migration (51, 67–69) leading to a thin-
ning of the cortex (69) and implying an overlapping role 
with NDE1. This seemingly occurs due to uncoupling of the 
centrosome from the nucleus (68), an effect which is exag-
gerated when Lis1 expression is also knocked-out (51, 69). 
Aberrant positioning of both embryonic and adult-born 
hippocampal neurons (51, 69, 70) and of neurite extension 
in dorsal root ganglia (71) have also been reported follow-
ing NDEL1 depletion.
A number of additional functions for NDEL1 have 
also been reported including its facilitation of neurofila-
ment polymerization (72), promotion of axonal regen-
eration (73), regulation of Cdc42 at the leading edge of 
migrating neurons (74), regulating the GTPase activity 
of the microtubule remodeling protein Dynamin 2 (75), 
facilitating the actin polymerization-promoting activ-
ity of the WAVE complex (76) and a peptidase activity 
(77). It is not currently known whether NDE1 shares any 
of these functions. For more detail on the cytoskeletal 
functions of NDEL1 and its role in signaling pathways, 
readers are referred to the comprehensive review by 
Chansard et al. (78).
It is therefore apparent that, in terms of the regula-
tion of dynein, effects on mitotic progression and regu-
lation of cortical neuronal development and migration, 
NDE1 and NDEL1 possess functions which largely overlap 
and that the two proteins are able, to some extent, to 
compensate for the loss of one another. Several lines of 
evidence suggest that the two proteins are not fully redun-
dant, however, notably the potential differences in their 
dynein-related regulation of mitotic checkpoints (58), 
overlapping but distinct regions of binding to the dynein 
protein complex (1, 2, 46, 49), the difference in viability of 
Nde1 and Ndel1 knockout mice (51, 57) and the dramatic 
microcephaly phenotypes seen in patients with loss of 
functional NDE1, but presumably not functional NDEL1 
(41–44). There also remain a large number of functions of 
one of the paralogs, for which the importance of the other 
is undetermined. There are also notable differences in the 
expression of the two proteins over development, at the 
mRNA level (Figure 2). According to data from the Human 
Brain Transcriptome project [hbatlas.org; ref. (79)], while 
expression of NDEL1 across the brain is relatively steady 
throughout the lifetime, NDE1 is considerably higher 
during the first couple of months after fertilization, before 
dropping dramatically at birth. A smaller increase in NDE1 
expression is also notable in some brain regions in early 
childhood. Given the high degree of amino acid conserva-
tion between NDE1 and NDEL1 (Figure 1; Table 1), we will 
now discuss the potential basis of some of these similari-
ties and differences: how do their structures compare? Do 
the NDE1 and NDEL1 proteins function differently, or are 
they proteins with a common function, but with distinct 
regulation?
NDE1 and NDEL1 have a similar 
nature: sequence, structure and 
oligomeric state
At the sequence level, NDE1 and NDEL1 share approxi-
mately 60% amino acid sequence identity (∼80% 
sequence similarity) and are thought to have evolved 
from a common ancestral gene (1–5). This duplication 
and divergence into two genes appears to have occurred 
around the time of the emergence of vertebrate species 
(54), with NDEL1 orthologs showing greater inter-species 
conservation compared to NDE1 orthologs (Table 1). Mul-
tiple isoforms for both proteins have been confirmed, 
mainly consisting of a variety of alternative extreme C-ter-
minal regions (33). Both evolutionarily conserved proteins 
have a highly conserved N-terminal half (residues ∼1–185), 
while the C-terminal sequence is comparatively more 
variable (Figure 1). Sequence analysis revealed predomi-
nance of the classical ‘heptad’ repeat that could confer the 
coiled-coil motif to the N-terminal ∼190 amino acids (80).
Early structure-based work focused exclusively on 
NDEL1. Sasaki et  al. showed that full-length murine 
Ndel1 interacted strongly with itself, and by means of 
yeast two-hybrid based assays using NDEL1 truncation 
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Table 1 Sequence comparison of NDE1 and NDEL1 shows greater conservation of NDEL1 across vertebrate species.
Cow 88.66 Amino acid conservation in NDE1 (% identity)
(Bos 99.13 Amino acid conservation in NDEL1 (% identity)
taurus) -10.47 Difference in conservation (% identity)
Mouse 85.89 87.50
(Mus 95.94 96.52
musculus) -10.05 -9.02
Rat 83.13 84.59 91.57
(Rattus 95.94 96.52 100.00
norvegicus) -12.81 -11.93 -8.43
Chicken 73.33 73.90 73.45 72.27
(Gallus 92.13 92.71 90.67 90.67
gallus) -18.80 -18.81 -17.22 -18.40
Frog 68.56 66.96 67.06 65.60 67.74
(Xenopus 81.23 81.52 80.35 80.35 83.48
tropicalis) -12.67 -13.56 -13.29 -14.75 -15.74
Zebrafish 58.54 57.93 57.98 58.28 58.95 56.50
(Danio 72.19/76.33 71.89/76.04 70.41/74.56 70.71/74.56 71.73/75.30 69.03/71.98
rerio) -13.65/-17.79 -13.96/-18.11 -12.43/-16.58 -12.13/-16.28 -12.78/-16.35 -12.53/-15.48
Human Cow Mouse Rat Chicken Frog
(Homo (Bos (Mus (Rattus (Gallus (Xenopus
sapiens) taurus) musculus) norvegicus) gallus) tropicalis)
The percentage amino acid sequence identity was compared using Clustal Omega (108, 109) after alignment shown in Figure 1. All-against-
all pairwise inter-species percentage identity for NDE1 is shown on the top row on a lighter gray background, and for NDEL1 on the middle 
row on a white background. The difference between these values is shown on the bottom row in bold type on a darker gray background. As 
there are two NDEL1 genes in zebrafish (110), values for both encoded proteins are displayed, ndel1a on the left and ndel1b on the right. It 
can be seen that in every instance, between all species examined, NDEL1 is more highly conserved than NDE1.
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Figure 2 Differential expression of NDE1 and NDEL1 transcripts in the human brain across the lifetime. 
Change in NDE1 mRNA expression with time is shown in the left panel and NDEL1 in the right panel; developmental age shown on the x-axis 
in days; mRNA expression signal intensity (Log2) shown on the y-axis. While, expression of NDEL1 across the brain remains relatively 
steady, NDE1 shows a far more specialized pattern of expression. Abbreviations for brain regions used in figure: NCX, neocortex; STR, stria-
tum; HIP, hippocampus; MD, mediodorsal nucleus of the thalamus; AMY, amygdala; CBC, cerebellar cortex. Data and figure accessed from 
the Human Brain Transcriptome project (http://hbatlas.org/pages/hbtd; used with permission) (79).
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constructs, showed that this potential ‘homodimeri-
zation’ resided within the putative coiled-coil domain 
(amino acids 56–166) (1). The emergence of high-reso-
lution crystal structures and biophysical characteriza-
tion of an N-terminal coiled-coil domain fragment for rat 
Ndel1 (identical in amino acid sequence to human NDEL1 
for the region solved) (81) revealed a highly extended, 
continuous, tightly associating coiled-coil protein that 
facilitated both parallel dimerization and anti-parallel 
tetramerization (Figure 3); the latter composed of two 
parallel dimers associating in anti-parallel fashion. 
Initial chemical cross-linking analysis coupled with 
mass spectrometry (MS) supported the parallel dimer 
arrangement of NDEL1 in solution (82). High molecular 
weight-only species (∼400 kDa) for His6-tagged recombi-
nant NDEL1 were also noted (83), while predominantly 
tetrameric species of GB1-tagged NDEL1 were described 
by Narayanan et  al. using size-exclusion chromatogra-
phy and analytical ultracentrifugation (84). Tarricone 
et al. (85) showed that a dimer of NDEL1 was important 
for interaction with LIS1, and Narayanan et al. (84) sug-
gested that a stable tetramer was responsible for interac-
tion with DISC1. Sequence-analysis and homology-based 
modeling suggested that NDE1 could indeed form both 
the dimeric and tetrameric species, and coiled-coil ori-
entation (86), as observed in the equivalent NDEL1 
crystal structures (81). Monomeric (∼40 kDa) species of 
NDEL1 with a cysteine peptidase activity and composed 
of ∼40% β-sheet by circular dichroism have also been 
reported (77), but are inconsistent with the remainder of 
the biophysical literature on NDEL1.
Our more recent biophysical characterization using 
size-exclusion chromatography, circular dichroism, 
negative-stain electron microscopy, and chemical cross-
linking coupled with MS analysis and bioinformatics 
confirmed that both N-terminally His6-tagged NDE1 and 
NDEL1 exhibit similar secondary structure, tertiary struc-
ture and oligomeric state (87). Both proteins form dimers, 
tetramers and high molecular weight species in solution 
thus unifying disparate observations in the literature. The 
application of chemical cross-linking/MS methodology 
allowed investigation of the C-terminal regions and thus 
provided insight into the conformation and overall archi-
tecture of the native proteins and was the first biophysical 
study that investigated the structure of NDE1. The C-ter-
minal portion of the proteins was shown to ‘bend-back’, 
potentially using the proline-rich region in the C-terminal 
half of the protein that is predicted to be unstructured 
(88), and interact with the N-terminal coiled-coil domain 
(87). This result was consistent with functional observa-
tions of two disparate dynein binding sites on NDEL1 at 
its N- and C-termini (60, 89). Dynamic change in confor-
mation for NDEL1 was also previously observed (90), in 
keeping with the flexible role of the C-terminus. We also 
showed via a novel application of stable-isotope labeling 
in cell culture (SILAC) chemical cross-linking and MS that 
NDE1 can directly and physically interact with NDEL1 
through the formation of heterotetramers and higher oli-
gomeric species (87). This is in agreement with the obser-
vation that the two proteins exist within the same protein 
complex in the cell, as determined by co-immunoprecipi-
tation experiments (29, 33).
Tetramerization domain
Dimerization domain
LIS1-binding region
Y87 T132 S135
N
N
N
N
C
C
C
CC
C
N
N
NDEL1 dimer
NDEL1 Tetramer
Figure 3 Coiled-coil crystal structure of NDEL1 with known post-translational modifications mapped. 
Only three known PTMs map onto the crystal structure of the NDEL1 coiled-coil domain fragment (residues 8–167; PDB ID: 2V71); these side-
chains are shown in green and labeled on cartoon representations of the NDEL1 crystal structure, parallel dimer (top panel) and anti-parallel 
tetramer (bottom panel) (81); N- and C-termini for each chain and regions that facilitate dimerization and tetramerization are indicated. The 
essential LIS1-binding region on NDEL1 114–133 (96) is also shown (pink). Phosphorylation of NDE1 at T131 (directly equivalent to T132 of 
NDEL1) reduces its ability to interact with LIS1 (86). It can therefore be hypothesized that phosphorylation of T132 and/or S135 of NDEL1 may 
have similar effects on LIS1-binding. The Y87 site is highly solvent-exposed on the dimerization domain of coiled-coil structure and is thus 
readily accessible to kinases.
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NDE1 and NDEL1 have different 
nurture: post-translational 
modification
Early work revealed that NDEL1 (1, 2) was a phospho-
protein and NDE1 was predicted to contain similar post-
translational modifications (PTMs) (3, 4). Since then a 
number of phosphorylation sites, along with one palmi-
toylation site, have been experimentally demonstrated to 
exist in each protein, while a number of others have been 
suggested with high-throughput proteomic (HTP) experi-
ments using MS (91) (Figure 1; Table 2).
The vast majority of experimentally determined phos-
phorylation sites reside within unstructured regions of 
the proteins, predominantly in their C-terminal regions, 
in particular within the ‘flexible’ proline-rich linker 
region (87, 88) that connects the coiled-coil domain to 
the C-terminal α-helix, and others located towards their 
extreme C-termini. These unstructured regions are likely 
to be highly solvent-exposed and thus accessible to enzy-
matic action from protein kinases. Phosphorylation and 
other PTM sites are usually short motifs that occur within 
rapidly evolving unstructured regions (92). A number of 
these phosphorylation sites are not conserved between 
NDE1 and NDEL1; there are at least 18 sites specific to only 
one of the proteins (Figure 1). This is in keeping with the 
notion that rapid evolution of these sites may be linked 
to gene retention among highly similar duplicated genes 
such as NDE1 and NDEL1. These differences in PTM present 
a ready means of effecting functional rewiring (93).
A total of 32 sites have been shown to be post-
translationally modified in NDE1 and/or NDEL1 (Table 
2; where the equivalent residue is putatively modified 
in both proteins, this is counted only once). For some 
of the phosphorylation sites on NDE1 and NDEL1 the 
kinase or kinases responsible have been identified, 
while others can be speculated by means of a kinase pre-
diction search of their respective sequences using Net-
PhosK (94). These results taken together show NDE1 and 
NDEL1 are substrates for a wide array of kinases (Table 
2). It is well known that substrate specificity of protein 
kinases is highly dependent on the primary amino acid 
sequence immediately flanking the site of phosphoryla-
tion (95); these are classified into basophilic (prefer-
ence for positively charged amino acids, e.g., PKA and 
PKC), acidophilic (preference for negatively charged 
amino acids, e.g., CKI, CKII), proline-directed kinases 
(preference for proline, e.g., Cdk1, Cdk5, Erk2, GSK-3, 
MAPK) and other kinases. Both NDE1 and NDEL1 have 
proline-rich linker regions between their N-terminal 
Table 2 Post-translational modification on NDE1 and NDEL1.
NDE1 
residue
Known or  
predicted kinase/
enzyme
NDEL1 
residue
Known or predicted 
kinase/enzyme
T7-p CKI
S9-p CKII
Y87-p SRC
T131-p PKA (86) T132-p PKA
S135-p –
T191-p p38MAPK, GSK3
S194-p CKI, PKC, PKA
S197-p CKI
S198-p Cdk1, Cdk5 (2, 97)
S211-p PKC S215-p PKC
S214-p –
T215-p Cdk1 (41) T219-pa Cdk1, Cdk5, Erk2 (2, 
96, 97)
S223-p RSK, PKC, PKA
S224-p –
T228-p p38MAPK, Cdk5 S231-pa Cdk1, Cdk5 (2, 97)
S231-p PKC, Cdk1
S239-p –
T240-p –
T243-p Cdk1, Cdk5 S242-p Cdk1 (96)
T246-p Cdk1 (41) T245-p Erk2 (96)
S251-p Aurora-A kinase (97)
C274-s DHHC2, 3, 7 (54) C273-s DHHC2, 3, 7 (54)
Y279-p –
S282-p p38MAPK, Cdk5
S282-p PKC
S291-p PKC
T301-p PKC
S306-p PKA (88)
S307-p –
T308-p –
S309-p Cdk1
S336-p Aurora-A and B 
kinases (101)
Experimentally determined phosphorylation sites (indicated with 
‘-p’) from the literature and HTP/MS screens and palmitoylation 
sites (indicated with ‘-s’) are shown for each protein along with cor-
responding known kinase/enzyme or NetPhosK v1.0 (94) predicted 
kinase (stringency prediction threshold = 0.5). Where PTM occurs 
at the equivalent amino acid position in NDE1 and NDEL1 follow-
ing alignment (Figure 1), these are shown side-by-side. Where the 
kinase/enzyme is known, these are shown in bold type and their 
corresponding reference provided; these PTMs are discussed 
in more detail in the text. All other phosphorylation sites were 
obtained from the PhosphoSitePlus database (91). aPhosphatase 
known: PP4c acts on T219 (104) and PP2 acts on S231 (100).
coiled-coil domain and predicted C-terminal α-helix, 
and are significantly enriched for phosphorylation 
sites therein; it is reasonable to assume that proline-
directed kinases are likely to act here. Indeed, both 
T215 and T246 in NDE1 that possess adjacent proline 
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residues are phosphorylated by proline-directed kinase 
Cdk1 (41). Likewise, known sites in NDEL1 – S198, 
T219, S231, S242 and T245 – are also located adjacent 
to proline residues and are phosphorylated by Cdk1, 
Cdk5 and/or Erk2 (2, 96, 97). The C-terminal regions 
of NDE1 and NDEL1 are highly basic in overall charge 
(87, 89) and are thus more amenable to basophilic 
kinases. In support of this, many of the C-terminal sites 
are suggested to be targets for PKA or PKC, with S306 in 
NDE1 experimentally verified as a PKA site (88). Future 
work should aim to experimentally verify the existence 
of the HTP/MS phosphorylation sites using additional 
techniques such as amino acid sequencing, phospho-
specific antibodies, site-directed mutagenesis, domi-
nant-negative constructs etc. and confirm the remaining 
kinases that act on NDE1 and NDEL1 based upon this 
exercise.
Structural landscape of post-trans-
lational modification: implications 
for NDE1 and NDEL1 function
In order to discuss in detail the potential and known 
effects of NDE1 and NDEL1 PTM, each structural domain 
or region of the proteins will now be considered in turn. 
Schematics displaying the overall PTM landscape on 
NDE1 and NDEL1 structure along with known protein-pro-
tein interaction sites are shown in Figure 4.
N-terminal coiled-coil domain
The N-terminal region of NDEL1 that is involved in the 
formation of oligomers through coiled-coil interactions 
NDE1
Coiled-coil domain α-helix
T131T7
S9
T191 S211
S214
T215
S224
S231
T240 C274
Y279
S291 S306
T308
S223
T228 S282 S307
S309S239
T246
T243
LIS1*
Centrosomal targeting
MCRS1*, Su48*
CENPF
Utrophin
Dynein (IC) Dynein (LC8)
* Interaction modulated by phosphorylation Phosphorylation site Palmitoylation site
LIS1*
Katanin p60*, 14-3-3ε*
DISC1
Y87 T132
S135 S197 S215 S231 S242
T301S282
C273
T245T219S194
S198
Coiled-coil domain α-helix
Centrosomal targeting
Dynamitin, pericentrin, paxillin
NF-L, Dynamin-2, Rabaptin-5
NDEL1
Dynein (HC), Cdc42GAP*Dynein (IC)
Lamin-B
Katanin p80
S336
S251
Gβ
Figure 4 Domain architecture, post-translation modification and binding/functional regions of NDE1 and NDEL1. 
Schematics of NDE1 (top panel) and NDEL1 (bottom panel) drawn to scale depicting the N-terminal coiled-coil domain and the predicted 
C-terminal α-helix (labeled); the central flexible linker region connects these two structured regions, while another unstructured region lies 
at the extreme C-terminus of the proteins. Numerous PTMs (stars) reside within delineated protein-protein interaction sites, sub-cellular 
localization regions, or oligomerization domains with the vast majority located within predicted unstructured regions of the proteins. 
Minimal essential protein-binding sites from the literature are shown drawn to scale (NDE1: green bars; NDEL1: purple bars). References for 
each NDE1 interaction site are as follows: Centrosomal targeting (98); Centromere protein F (CENPF)/Mitosin/LEK1 (112); LIS1 (4); Utrophin 
(66); MCRS1/p78 (99); Su48/ DBZ/ZNF365 (98); Dynein IC (89); Dynein (LC8) (49). References for each NDEL1 interaction site are as follows: 
Centrosomal targeting (113); LIS1 (96); Dynamitin (50); Pericentrin/Kendrin (113); Paxillin (114); G-protein β (Gβ) (115); DISC1 (28); Katanin 
p60 and p80 (68); 14-3-3ε (100); Neurofilament (NF)-L (72); Dynamin-2 (75); Rabaptin-5 (78); Dynein intermediate chain (IC) (89); Dynein 
heavy chain (HC) (1); Cdc42GAP (74); Lamin-B (63). Note: the palmitoylation site C273 (red star) on NDEL1 is also the site of endooligopepti-
dase activity (77). In the majority of cases, these sites have only been investigated for one of NDE1 or NDEL1; it is likely that some of them 
will be conserved between the two proteins. The effect of PTMs should be tested on protein conformation, stability, oligomerization, modu-
lation of protein-protein interaction and cellular trafficking/targeting.
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remains the only region of the two proteins to be experi-
mentally determined by crystallography (81), allowing 
the locations of the known phosphorylation sites in this 
region to be mapped on its three-dimensional structure 
(Figure 3).
Only three phosphorylation sites are known to reside 
within the N-terminal 190-amino acid coiled-coil-con-
taining region for each of NDE1 and NDEL1 to date. NDE1 
was shown to be phosphorylated by PKA at T131 with 
both DISC1 and phosphodiesterase 4 (PDE4), interac-
tion partners of NDE1, able to modulate this post-trans-
lational event (86). Phosphorylation of this site causes 
increased interaction of NDE1 with NDEL1 in COS7 cells, 
but decreased interaction with LIS1 (86). Given that this 
region of NDE1 and NDEL1 governs their oligomerization/
tetramerization state (81, 87) and that NDE1 and NDEL1 
are capable of interacting in the same manner as NDE1 
and NDEL1 homomeric species (87), one possibility is that 
this site may modulate the dimeric vs. tetrameric state of 
NDE1 generally, with the observed effect on hetero-oli-
gomerization of NDE1-NDEL1 representing a special case 
of this. The HTP/MS-derived phosphorylation site at S135 
of NDEL1 would likewise be predicted to impact on similar 
processes given its similar characteristics to T131, such as 
its location within an incomplete heptad repeat within the 
tetramerization domain (81, 86) and proximity to the LIS1-
binding region (Figure 3). Potentially as a consequence 
of this, expression of NDE1 with a T131 phosphomimic 
mutant leads to decreased neurite outgrowth in a NS-1 cell 
assay (86). Based on amino acid sequence identity, NDEL1 
would be predicted to be phosphorylated at its equivalent 
site, T132, however two studies have been unsuccessful in 
demonstrating this (86, 90), although it has been detected 
in a single HTP/MS screen (91). An antibody which could 
recognize both T131-phosphorylated NDE1 and putative 
T132-phosphorylated NDEL1 species, showed such species 
to be present at post-synaptic densities and cortical 
primary axons of mice, and to remain at the spindle poles 
of COS7 cells throughout cell mitosis, in contrast to non-
phosphorylated species (86).
Central flexible linker region
As previously noted, the unstructured region between the 
N-terminal coiled-coil and predicted C-terminal α-helix of 
both NDE1 and NDEL1 are highly phosphorylated, with 
NDEL1 being a substrate for Cdk5 at S198, T219 and S231 
(2). Cdk1 has been variously reported to either phosphoryl-
ate these sites or T219, S242 and T245 (96, 97), while Erk2 
acts at T219 and T245 (96). Equivalent phosphorylation of 
NDE1 is less well studied; however, it is known to be a sub-
strate for Cdk1 (98), which acts on T215, T246 and at least 
one additional undefined site (41). Cross-talk between 
these kinases also occurs, with use of a dominant-nega-
tive version of Cdk5 preventing Cdk1 from phosphorylat-
ing S231 of NDEL1, while the reverse was not true when a 
dominant-negative form of Cdk1 was used (62).
Several studies have looked at the expression and 
function of NDEL1 species in which five putative phos-
phorylation sites in this region (S198, T219, S231, S242 and 
T245), including all known Cdk1, Cdk5 and Erk2 sites were 
substituted to make either phosphodead alanine or valine 
residues, or to mimic phosphorylation with glutamic acid 
residues. NDEL1 carrying phosphodead mutations of all 
five of these residues are found prominently at the cen-
trosome during interphase, as was wild-type NDEL1; in 
contrast, NDEL1 with five phosphomimic residues was 
only weakly detectable there (96). Similarly, the phos-
phomimic failed to transfer to the spindle poles during 
telophase in the manner of wild-type NDEL1; by contrast, 
the phosphodead mutant was prominent at the spindle 
from metaphase (96). Phosphorylation of NDEL1 therefore 
appears to block its spindle localization until the appro-
priate part of the cell cycle. Similar results were also seen 
when five putative phosphorylation sites in this region of 
NDE1 (T191, T215, T228, T243 and T246), plus one imme-
diately C-terminal of its predicted α-helix (S282), were all 
mutated to phosphodead alanine or valine residues (98). 
Dramatically, knock-out of one such site on NDE1, T246, 
arrested mitotic HEK293T cells at the G2/M phase bound-
ary (41).
Phosphorylation of residues in the central flexible 
linker region have been shown to modulate the interac-
tions with other centrosomal proteins, specifically of 
NDE1 with the centrosomal protein Su48 (also known 
as DBZ or ZNF365) (98) and mitotic protein Microspher-
ule protein 1 (MCRS1; also known as p78) (99), as well as 
the interactions of NDEL1 with the microtubule severing 
protein katanin (68) and 14-3-3ε (100) (Figure 4); although 
other phosphorylation events have been reported to have 
a greater impact upon 14-3-3ε interaction (101). Mock 
phosphorylation of NDEL1 at these residues also leads to 
increased activation of Cdc42GAP (74). Of particular inter-
est though is the effect of these phosphorylation events 
on LIS1 and dynein. Application of either Cdk1 or Cdk5 
to NDEL1 led to an increase in its interaction with LIS1, 
while causing dissociation of LIS1 to dynein (62). Success-
ful dissociation of LIS1 is vital in the process by which 
dynein moves along microtubules with its cargo (102) 
and the importance of NDEL1 phosphorylation in this is 
seemingly demonstrated by the fact that expression of 
Brought to you by | University of Edinburgh
Authenticated | 129.215.35.9
Download Date | 4/30/14 11:23 AM
456      N.J. Bradshaw et al.: Comparative assessment of NDE1 and NDEL1
mutant NDEL1 lacking the five putative phosphorylation 
sites, or expression of a dominant-negative Cdk5 mutant, 
each effectively abolished dynein-related organelle trans-
port along the axons of rat neurons (103). It is therefore 
possible that Cdk5 as well as potentially Cdk1 and Erk2 
phosphorylation of NDEL1 may modulate dynein activ-
ity through altering LIS1-dynein interaction. Mutation of 
NDEL1 residues T219 and T245 was also shown to block 
NDEL1-dynein interactions (89). Other dynein-related 
effects of phosphorylation sites in this region are known; 
they are required to increase prophase nuclear envelope 
invagination in response to Cdk1 or Cdk5 (62), while their 
mutation inhibits cell migration during scratch-wound 
assays (74).
It has recently been shown that the C-terminal α-helix 
of NDE1 and NDEL1 can interact directly with its N-ter-
minal coiled-coil domain (87) facilitated by this central 
proline-rich unstructured region that permits a bent-back 
conformation. It is therefore reasonable to suggest that 
many of the effects attributed to phosphorylation of resi-
dues in this region could be a consequence of regulation 
of this conformational process. For example, the effects on 
dynein function may occur because altered phosphoryla-
tion of this region affects the ability of NDE1 and NDEL1 
to bring their distinct N- and C-terminal dynein binding 
domains (60, 89) into close physical proximity.
At least two separate phosphatases are involved in the 
removal of phosphate groups from this region of NDEL1, 
with protein phosphatase 4 catalytic subunit (PP4c) acting 
on T219 (104) and protein phosphatase 2 (PP2) acting on 
S231 (100) (Table 2). Interestingly, the former phosphatase 
is present at the centrosome at all times except during 
mitosis, suggesting that it may be involved in temporal 
regulation of NDEL1 function there (104).
Predicted C-terminal α-helix
The predicted α-helix of NDEL1 (87, 88) contains the DISC1 
binding site (28) and overlaps with the ‘minimally’ defined 
binding regions of the dynein heavy chain (1) (Figure 4). 
The most investigated PTM in this region, is phosphoryla-
tion of NDEL1 by Aurora-A kinase at S251 during prophase, 
with expression of a NDEL1-S251E phosphomimic mutant 
being sufficient to rescue mitotic entry defects caused by 
Aurora-A knockdown (97). At the end of prophase, these 
phosphorylated NDEL1 species rapidly disappear, seem-
ingly due to ubiquitination followed by degradation by the 
proteasome (97). This phosphorylation event also occurs 
in post-mitotic neurons, where phosphorylation of NDEL1 
at S251 occurs as a result of Aurora-A-kinase activation by 
PKC-ζ at connections of the neuronal soma with neurites 
(71). Disruption of the function of any of PKC-ζ, Aurora-A 
kinase or NDEL1, variously by use of pseudo-substrates, 
kinase-deficient mutants or RNAi, led to decreased 
neurite extension in dorsal root ganglia neurons (71). 
Expression of a NDEL1-S251E phosphomimic mutant was 
also able to rescue migration defects in granular neurons 
caused by either conditional knockdown of endogenous 
NDEL1 or inhibition of Aurora-A kinase (105). The mecha-
nism by which S251 phosphorylation causes these effects 
is unclear, although one possibility emerges from the fact 
that, unlike wild-type NDEL1, an S251A phosphodead 
mutant was not able to interact with dynein (89).
Additionally, NDEL1 is known to interact with 14-3-3ε 
as well as potentially 14-3-3α/β, γ, τ and ζ (100). S251 of 
NDEL1 is a good match for the canonical phosphoryla-
tion-dependent binding site of 14-3-3 proteins and indeed 
mutation of S251 to alanine reduces NDEL1 interaction 
with 14-3-3 (101). Additionally, interaction between recom-
binant forms of the two proteins is increased following 
Aurora-A kinase treatment (101).
NDEL1 can also be palmitoylated within this predicted 
helix at C273 by three enzymes, DHHC2, 3 and 7, causing 
a reduction in interaction between NDEL1 and dynein and 
an increase in NDEL1 at neurite tips, indicating reduced 
retrograde transport by dynein (54). Other evidence that 
NDEL1 palmitoylation limits dynein function can be seen 
through its impaired ability to transport proteins, short 
microtubules and Golgi vesicles following co-transfection 
of DHHC and wild-type NDEL1, but not when a DHHC 
and a NDEL1-C273S palmitoylation-resistant mutant or 
NDEL1 alone were used (54). It has also been reported that 
expression of NDEL1 with a C273A mutation inhibits the 
growth of neurites of PC12, in contrast to wild-type NDEL1 
which increases it, although a specific role of palmitoyla-
tion in this process has not been established (106). Simi-
larly, wild-type, but not C273A, NDEL1 can rescue neurite 
outgrowth defects caused by knockdown of endogenous 
NDEL1 (106). NDE1 can also be palmitoylated at its equiv-
alent site, C274, by the same DHHC enzymes as NDEL1; 
however, strikingly, palmitoylation of NDE1 had no effect 
on its interaction with dynein or any of the other func-
tional tests of NDEL1 palmitoylation, indicating a funda-
mental difference in the function of NDE1 and NDEL1 (54).
C273 is also the catalytic residue for the oligopepti-
dase activity of NDEL1 (77), although it remains unclear 
whether this is blocked by palmitoylation, or whether the 
effect on neurite outgrowth ascribed to NDEL1 species in 
which C273 has been mutated is due to altered enzymatic 
activity, altered interaction with dynein or a combination 
of the two. The possibility exists that this palmitoylation 
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event may act as a switch between these two, seemingly 
distinct, functions of the NDEL1 protein. Although the 
putative catalytic cysteine residue is also present in NDE1, 
no study to date has investigated whether it also possesses 
a similar oligopeptidase activity.
Extreme C-terminal unstructured region
The extreme C-terminal region of NDE1 and NDEL1 is 
known to interact with a number of different protein 
binding partners, and it is therefore likely that the PTMs 
within this region influence NDE1 and NDEL1 function at 
least in part through regulation of these interactions. Of 
these, NDE1 is known to be phosphorylated by PKA at S306 
(88), in a DISC1- and PDE4-modulated process (86), while 
the equivalent residue in NDEL1 is non-phosphorylatable 
(Figure 1). The function of this site remains unknown; 
however, NS-1 cells expressing NDE1-S306D phosphom-
imic mutants display an increase in neurite number com-
pared to those expressing phosphodead S306A mutants 
(86). It is notable that proteomics screening implies S306 
is part of a cluster of four directly concurrent phosphoryl-
ated residues, three of which are specific to NDE1 (Figure 1). 
The functional significance of this cluster remains to be 
determined.
Additionally, NDEL1 has a serine at residue 336 which 
can be phosphorylated by Aurora-A and -B kinases, cre-
ating a 14-3-3 binding site (101). Mutation of this site to 
alanine has a greater effect on 14-3-3 interaction than 
similar mutation of S251 described earlier, with muta-
tion of both abolishing the majority of interaction (101). 
Notably, however, this site exists only within a specific 
isoform of NDEL1 and because both NDE1 and NDEL1 are 
known to exist as multiple splice variants, many of which 
vary only in their extreme C-termini (33) it can therefore 
be speculated that one purpose of the multiple splice 
variants is to introduce alternative PTM regulation at the 
extreme C-terminus of a specific subset of NDE1/NDEL1 
molecules in vivo, and potentially ones with unique pat-
terns of temporal or spatial expression with the organism.
Conclusions
Since their first description, NDE1 and NDEL1 have 
emerged as key players in mitosis and neurodevelopment 
with overlapping yet distinct functional profiles. While 
they share high sequence similarity and have been shown 
to adopt similar structure and oligomeric states, they are 
clearly differentially regulated post-translationally. A 
mass of PTM data has emerged for the two proteins over 
the past decade and recent HTP data via tandem MS will 
continue to inform on regulatory mechanisms of protein 
function. Notwithstanding the expert manually curated 
effort of the PhosphoSitePlus database (91) to cata-
logue experimentally determined PTM sites, it should be 
borne in mind there could be some data quality issues 
for assignments; false positives and/or incorrect assign-
ments to either NDE1 or NDEL1, given their high sequence 
identity, is a possibility, especially for some of the sites 
identified purely via MS/HTP-discovery, whose assign-
ments are probabilistic by nature. Nonetheless, nine out 
of ten sites verified in the primary literature for NDE1 and 
NDEL1 were seen in the MS-only assignments in the data-
base suggesting a high true positive rate. Even for the one 
site T131 in NDE1, not discovered by MS, the equivalent 
NDEL1 site (T132) was indeed observed. Additionally, for 
each protein  > 50% of sites assigned only using the MS/
HTP criteria had five or more references corresponding to 
each site in the database, indicating a high potential for 
these sites to be true positives too. Conversely, it should 
also be noted that there could be a failure to detect some 
of the phosphorylation sites in a protein sample because 
of the inherent sensitivity of the methodology whereby the 
phosphate groups can be lost during sample preparation 
and analysis. Hence, failure to detect phosphorylation 
should not necessarily be considered as evidence that the 
site in not actually phosphorylated under certain relevant 
conditions (107).
A major issue in clarifying the relationship between 
NDE1 and NDEL1 remains the relative lack of directly com-
parable information between them. For example, while 
there are some proteins confirmed to be interaction part-
ners of both NDE1 and NDEL1, there are a greater number 
which are known to interact with NDEL1, but for which 
comparable interaction studies with NDE1 have not yet 
been performed (Figure 5). Some examples of protein 
interaction partners proven to bind NDE1, but not yet 
tested for NDEL1, also exist.
From the information currently available, however, it 
is possible to begin to speculate on the fundamental dif-
ferences between the NDE1 and NDEL1 proteins which 
have warranted their conserved existence throughout 
vertebrate evolution. Functionally, the proteins appear to 
be highly similar, but with potential differences in dynein 
binding (49) and mitotic function (58). By contrast, their 
post-translational regulation is distinct; this suggests 
that, due to the fundamental roles the two proteins play 
in neuronal function, the existence of two distinct ‘NudE-
derived’ proteins allows a tighter level of regulation of 
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their roles. It is also noteworthy that while Ndel1 knock-
out mice are not viable (51), Nde1 knock-out mice survive 
to birth (57). We therefore hypothesize that while NDEL1 
plays the “core” role, conserved across evolution of NDE1/
NDEL1 orthologs, NDE1 can act as an ancillary version, 
providing additional or perhaps slightly modified ver-
sions of the common NDE1/NDEL1 functions where 
necessary under a different system of regulation. Such dif-
ferences are likely to be both temporal, with NDE1 having 
a more specialized pattern of expression during early neu-
rodevelopment, and spatial, with NDEL1 known to have 
both cortical and hippocampal developmental functions 
(51), while NDE1 has mainly been described as affecting 
the cortex (57). An alternative theory to explain the mouse 
viability, i.e., Ndel1 has a specific essential function in 
the early blastocyst, must also be considered. The former 
model would, however, be consistent with the relatively 
higher conservation of NDEL1 throughout evolution, com-
pared to the more recent, faster evolution of NDE1 (54) 
(Figure 1; Table 1). This would also be consistent with the 
apparent role of NDE1 CNVs in mental health and other 
neurodevelopmental conditions: while gross disruption of 
the more ‘essential’ NDEL1 protein would be critical and 
perhaps incompatible with life, disruption of NDE1 causes 
more subtle effects by comparison, notwithstanding the 
gross microcephaly phenotypes associated with complete 
loss of NDE1 function. The issue of exactly when and 
where NDE1 and NDEL1 perform their functions is further 
complicated by their ability to form hetero-oligomers 
(29, 33, 87), leading to the possibility of unique functions 
of a mixed NDE1-NDEL1 species, in addition to those per-
formed by each protein alone. Teasing apart this relation-
ship remains an important avenue for future research; 
research that will be of significant importance in under-
standing their shared and specific roles in psychiatric dis-
orders and neurodevelopment.
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Figure 5 Protein interaction partners of NDE1 and NDEL1. 
Proteins in the left circle interact with NDE1, those in the right circle with NDEL1. Proteins in the intersecting region are known to interact 
with both proteins. In the majority of instances where a protein is listed as interacting with only one of NDE1/NDEL1, the reciprocal experi-
ment to test for interaction with the other of NDEL1/NDE1 has not been published to the best of our knowledge. Proteins listed in italics are 
known to exist in a complex with NDE1/NDEL1 but do not, or have not yet been shown to, directly bind to it. Data are taken from the follow-
ing papers (1–5, 27–29, 31–33, 48, 50, 53, 57, 58, 63, 65, 66, 68, 72, 74–76, 78, 80, 88, 90, 96–98, 100, 101, 113–121). In some cases the 
essential binding regions for these interaction partners have been delineated on NDE1 or NDEL1; these are shown schematically in Figure 4.
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